Kyoto, Japan

Yoshiyuki Nishikawa

This inventor holds 1 USPTO granted patent. Top assignee: Immuno Japan Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyuki Nishikawa. Retrieved from https://idiyas.com/inventor/yoshiyuki-nishikawa-16ukeij8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshiyuki Nishikawa: Revolutionizing Pain Relief in Kyoto, JP

Introduction: Yoshiyuki Nishikawa, an esteemed inventor based in Kyoto, Japan, has made significant contributions to the field of pharmaceuticals. With a keen focus on analgesic and anti-inflammatory medicines, Nishikawa's innovative work has led to the development of a crucial patent that promises to enhance pain management for many.

Latest Patents: Nishikawa holds a notable patent for an analgesic and anti-inflammatory medicine, which combines ascorbic acid and/or its derivatives with aspirin and/or its derivatives. This composition not only serves as an effective analgesic but also aims to reduce the side effects commonly associated with aspirin use. His method of administration includes an effective amount of this pharmaceutical combination, marking a significant advancement in therapeutic treatments.

Career Highlights: Currently, Nishikawa is affiliated with Immuno Japan Inc., where he has been able to apply his innovative expertise in a collaborative environment. His dedication to research and development within the company reflects his commitment to improving healthcare solutions through targeted pharmacological advancements.

Collaborations: Working alongside Tetsuo Nakamura, Nishikawa has fostered a productive collaborative relationship that bolsters their combined efforts to innovate in the pharmaceutical space. Together, their research initiatives have the potential to bring forth new therapies that address common medical challenges faced by patients today.

Conclusion: In conclusion, Yoshiyuki Nishikawa's pioneering work in the realm of analgesics and anti-inflammatory medicines exemplifies the spirit of innovation that can lead to transformative changes in patient care. His patent not only elucidates a new approach to pain management but also sets the stage for future advancements in pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…